SymbolZTS
NameZOETIS INC.
SectorHEALTH CARE
RegionNorth America
IndustryBiotechnology: Pharmaceutical Preparations
Address10 SYLVAN WAY, PARSIPPANY, New Jersey, 07054, United States
Telephone+1 973 822-7000
Fax
Email
Websitehttps://www.zoetis.com
IncorporationUNDEFINED
Incorporated On
Employees
Fiscal Year
Public Since
ExchangesNASDAQ
Auditor
Audit StatusNOT PROVIDED
Reporting Status
CIK0001555280
Description

Zoetis sells anti-infectives, vaccines, parasiticides, diagnostics, and other health products for animals. The firm earns slightly less than half of total revenue from production animals (cattle, pigs, poultry, and so on), and more than half from companion animal (dogs, horses, cats) products make up the other half. Its U.S. business is heavily skewed toward companion animals, while its international business is slightly skewed toward production animals. The firm has the largest market share in the industry and was previously Pfizers animal health unit.

Additional info from NASDAQ:
Zoetis sells anti-infectives, vaccines, parasiticides, diagnostics, and other health products for animals. The firm earns slightly less than half of total revenue from production animals (cattle, pigs, poultry, and so on), and more than half from companion animal (dogs, horses, cats) products make up the other half. Its U.S. business is heavily skewed toward companion animals, while its international business is slightly skewed toward production animals. The firm has the largest market share in the industry and was previously Pfizers animal health unit.

2026-08-13 19:51

Zoetis Receives Emergency Use Authorization for Simparica Trio® (sarolaner, moxidectin, and pyrantel chewable tablets) for Treatment of New World Screwworm Infestations in Dogs and Puppies

Read more
2026-08-11 20:52

Director DAMELIO FRANK A 🔴 sold 6.7K shares of Zoetis Inc. (ZTS) Transaction Date: Aug 07, 2026 | Filing ID: 055777

Read more
2026-08-06 11:00

Zoetis Announces Second Quarter 2026 Results

Read more
2026-08-06 11:00

Zoetis Appoints Jay Saccaro as Chief Financial Officer and Chief Operating Officer

Read more
2026-07-24 19:43

Zoetis Inc. (ZTS) Shareholders Who Lost Money Have Opportunity to Lead Securities Fraud Lawsuit

Read more
2026-07-23 14:00

INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in Zoetis Inc. of Class Action Lawsuit and Upcoming Deadlines - ZTS

Read more
2026-07-22 16:00

Deadline Soon: Zoetis Inc. (ZTS) Shareholders Who Lost Money Urged To Contact The Law Offices of Frank R. Cruz About Securities Fraud Lawsuit

Read more
2026-07-22 11:30

Zoetis Launches Portela® (relfovetmab) in Canada and the European Union

Read more
2026-07-21 16:00

Zoetis Inc. (ZTS) Shareholders Who Lost Money Have Opportunity to Lead Securities Fraud Lawsuit

Read more
2026-07-21 14:05

ZTS Shareholder Alert: Zoetis Inc. Securities Class Action Lawsuit - Investors With Losses May Contact The Gross Law Firm

Read more